126 related articles for article (PubMed ID: 19904021)
1. Frequency of common CYP3A5 gene variants in healthy Polish newborn infants.
Adler G; Łoniewska B; Parczewski M; Kordek A; Ciechanowicz A
Pharmacol Rep; 2009; 61(5):947-51. PubMed ID: 19904021
[TBL] [Abstract][Full Text] [Related]
2. CYP3A5 variant allele frequencies in Dutch Caucasians.
van Schaik RH; van der Heiden IP; van den Anker JN; Lindemans J
Clin Chem; 2002 Oct; 48(10):1668-71. PubMed ID: 12324482
[TBL] [Abstract][Full Text] [Related]
3. Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population.
Fukuen S; Fukuda T; Maune H; Ikenaga Y; Yamamoto I; Inaba T; Azuma J
Pharmacogenetics; 2002 Jun; 12(4):331-4. PubMed ID: 12042671
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a rapid and reliable real-time PCR method for CYP3A5 genotyping.
Eidens M; Weise A; Klemm M; Fleischer M; Prause S
Clin Lab; 2015; 61(3-4):353-62. PubMed ID: 25975003
[TBL] [Abstract][Full Text] [Related]
5. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O
Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998
[TBL] [Abstract][Full Text] [Related]
6. Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients.
Provenzani A; Notarbartolo M; Labbozzetta M; Poma P; Vizzini G; Salis P; Caccamo C; Bertani T; Palazzo U; Polidori P; Gridelli B; D'Alessandro N
Int J Mol Med; 2011 Dec; 28(6):1093-102. PubMed ID: 21922127
[TBL] [Abstract][Full Text] [Related]
7. CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.
Hu YF; He J; Chen GL; Wang D; Liu ZQ; Zhang C; Duan LF; Zhou HH
Clin Chim Acta; 2005 Mar; 353(1-2):187-92. PubMed ID: 15698606
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.
Krishnakumar D; Gurusamy U; Dhandapani K; Surendiran A; Baghel R; Kukreti R; Gangadhar R; Prayaga U; Manjunath S; Adithan C
Fundam Clin Pharmacol; 2012 Apr; 26(2):295-306. PubMed ID: 21265876
[TBL] [Abstract][Full Text] [Related]
9. CYP3A5 polymorphism in Mexican renal transplant recipients and its association with tacrolimus dosing.
García-Roca P; Medeiros M; Reyes H; Rodríguez-Espino BA; Alberú J; Ortiz L; Vásquez-Perdomo M; Elizondo G; Morales-Buenrostro LE; Mancilla Urrea E; Castañeda-Hernández G
Arch Med Res; 2012 May; 43(4):283-7. PubMed ID: 22704849
[TBL] [Abstract][Full Text] [Related]
10. Interethnic differences of cytochrome P450 gene polymorphisms may influence outcome of taxane therapy in Roma and Hungarian populations.
Szalai R; Ganczer A; Magyari L; Matyas P; Bene J; Melegh B
Drug Metab Pharmacokinet; 2015 Dec; 30(6):453-6. PubMed ID: 26507668
[TBL] [Abstract][Full Text] [Related]
11. Frequencies of CYP3A5*1/*3 variants in a Moroccan population and effect on tacrolimus daily dose requirements in renal transplant patients.
Elmachad M; Elkabbaj D; Elkerch F; Laarabi FZ; Barkat A; Oualim Z; Sefiani A
Genet Test Mol Biomarkers; 2012 Jun; 16(6):644-7. PubMed ID: 22304537
[TBL] [Abstract][Full Text] [Related]
12. Molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa.
Bains RK; Kovacevic M; Plaster CA; Tarekegn A; Bekele E; Bradman NN; Thomas MG
BMC Genet; 2013 May; 14():34. PubMed ID: 23641907
[TBL] [Abstract][Full Text] [Related]
13. CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations.
Balram C; Zhou Q; Cheung YB; Lee EJ
Eur J Clin Pharmacol; 2003 Jun; 59(2):123-6. PubMed ID: 12756511
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population.
Hadjipanagi D; Chrysanthou S; Voskarides K; Deltas C
BMC Res Notes; 2014 Mar; 7():123. PubMed ID: 24593903
[TBL] [Abstract][Full Text] [Related]
15. Analysis of CYP3A5*3 and CYP3A5*6 gene polymorphisms in Indian chronic myeloid leukemia patients.
Sailaja K; Rao DN; Rao DR; Vishnupriya S
Asian Pac J Cancer Prev; 2010; 11(3):781-4. PubMed ID: 21039054
[TBL] [Abstract][Full Text] [Related]
16. Genetic diversity of
Adler G; Uzar I; Valjevac A; Kiseljakovic E; Mahmutbegovic E; Salkic NN; Adler MA; Mahmutbegovic N
Ann Hum Biol; 2022 Jun; 49(3-4):210-215. PubMed ID: 35815612
[TBL] [Abstract][Full Text] [Related]
17. CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population.
Muller WK; Dandara C; Manning K; Mhandire D; Ensor J; Barday Z; Freercks R
S Afr Med J; 2020 Jan; 110(2):159-166. PubMed ID: 32657689
[TBL] [Abstract][Full Text] [Related]
18. CYP3A5 3, CYP3A4 1B and MDR1 C3435T genotype distributions in Ecuadorians.
Sinués B; Vicente J; Fanlo A; Mayayo-Sinués E; González-Andrade F; Sánchez-Q D; Martínez-Jarreta B
Dis Markers; 2008; 24(6):325-31. PubMed ID: 18688081
[TBL] [Abstract][Full Text] [Related]
19. CYP3A5 genotypes and risk of oesophageal cancer in two South African populations.
Dandara C; Ballo R; Parker MI
Cancer Lett; 2005 Jul; 225(2):275-82. PubMed ID: 15978331
[TBL] [Abstract][Full Text] [Related]
20. Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and Other Caucasian populations.
Gervasini G; Vizcaino S; Gasiba C; Carrillo JA; Benitez J
Ther Drug Monit; 2005 Dec; 27(6):819-21. PubMed ID: 16306861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
